Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables - Wikidata - awgldk - TriplyDB

Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables

Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables

http://www.wikidata.org/entity/Q26865426

about

Systemic and renal oxidative stress in the pathogenesis of hypertension: modulation of long-term control of arterial blood pressure by resveratrol An update on immune system activation in the pathogenesis of hypertension Targeting on Asymmetric Dimethylarginine-Related Nitric Oxide-Reactive Oxygen Species Imbalance to Reprogram the Development of Hypertension Interplay between Oxidative Stress and Nutrient Sensing Signaling in the Developmental Origins of Cardiovascular Disease.The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease.Renal dopamine receptors, oxidative stress, and hypertension.Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart.An assessment of correlation between serum asymmetric dimethylarginine and glycated haemoglobin in patients with type 2 diabetes mellitus Activation of nuclear factor erythroid 2-related factor 2 coordinates dimethylarginine dimethylaminohydrolase/PPAR-γ/endothelial nitric oxide synthase pathways that enhance nitric oxide generation in human glomerular endothelial cells.Endothelial cell metabolism in normal and diseased vasculature.Voluntary exercise decreases atherosclerosis in nephrectomised ApoE knockout mice Redox Control of Protein Arginine Methyltransferase 1 (PRMT1) Activity.Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis--a randomized cross-over study.Protective effect of ginseng against gamma-irradiation-induced oxidative stress and endothelial dysfunction in rats.Vasodysfunction That Involves Renal Vasodysfunction, Not Abnormally Increased Renal Retention of Sodium, Accounts for the Initiation of Salt-Induced Hypertension.Plasma metabolomic profiles in different stages of CKD.Impact of high salt independent of blood pressure on PRMT/ADMA/DDAH pathway in the aorta of Dahl salt-sensitive rats.Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase.Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species Dopamine D1 and D5 receptors differentially regulate oxidative stress through paraoxonase 2 in kidney cells.Critical role of vascular peroxidase 1 in regulating endothelial nitric oxide synthase.Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications.L-Arginine and its metabolites in kidney and cardiovascular disease.Endothelial dysfunction and vascular disease - a 30th anniversary update.Asymmetric dimethylarginine is transported by the mitochondrial carrier SLC25A2.The para isomer of dinitrobenzene disrupts redox homeostasis in liver and kidney of male wistar rats.Oral warfarin and the thrombin inhibitor dabigatran increase blood pressure in rats: hidden danger of anticoagulants?NRF2 PREVENTS HYPERTENSION, INCREASED ADMA, MICROVASCULAR OXIDATIVE STRESS AND DYSFUNCTION IN MICE WITH TWO WEEKS OF ANGIOTENSIN II INFUSION.Reduced renal plasma clearance does not explain increased plasma asymmetric dimethylarginine in hypertensive subjects with mild to moderate renal insufficiency.Decreased diabetes risk over 9 year after 18-month oral L-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of L-arginine study).Regulation of fluid reabsorption in rat or mouse proximal renal tubules by asymmetric dimethylarginine (ADMA) & dimethylarginine dimethylaminohydrolase (DDAH) 1.

P2860

Q26999376-4E6B2CDA-A8F8-44EF-8D00-7A4E2FED435C Q27013715-16E27F76-1A79-43BC-9B4D-0231BEDE7D4F Q28069733-6C4D3DFE-44A4-4F09-B80D-8269CA9C86E0 Q30234757-21BD1A1D-0816-4FD8-8713-5D7B39A78EA1 Q30360038-237C0D59-4A2C-475A-9438-A5896ACA4B24 Q34367267-A0CD7CAE-4CB1-4818-8895-3E949A66851B Q34969073-1C651A13-91F0-44AF-9556-8319E1411D1D Q35099803-462ACAED-62EA-4FED-8837-EDB887ADD694 Q35175624-334FA7EA-092D-465A-9D07-79C0B040F0E3 Q35234625-446F2658-0FD0-4361-B0F9-CAECC7C6859A Q35584374-3AE23250-1182-45A1-84C9-3D768225E68D Q35721676-87327AC5-A568-45E0-A756-49F36654DC2C Q35818228-A049666C-BD68-4A0D-82FB-FB575338D9B4 Q36325484-933C0A7F-1596-4F1C-96BD-EF7C2463E50A Q36652055-2717A0C1-1F5E-4852-845E-C1E3E2112130 Q36652795-5F96CC90-B6BF-48C7-AD45-C76A0FE54BF2 Q36820553-3AF32912-0A7F-483C-95B5-E77BE7C425D8 Q36831934-40437368-F332-4FC9-AC2C-0BA061AA7BEA Q36926923-8545C693-D838-4867-819F-B14C70C5B0D2 Q37084544-D8A0DFD8-DCA7-40B0-8848-D247C0BBBEA2 Q37603724-8BEE200F-9CD9-4D69-900A-912EA2915AF2 Q37682579-622DC4D7-1F44-46D6-A6CF-C6A145D49B46 Q38016491-B778458F-2BC9-4AB4-AC7A-3C24BE592948 Q38243758-F36B26D1-D199-4896-987B-5D2D2C45C393 Q38680112-1460F3AC-9EEC-4D01-A3EA-53949565ED7B Q38832760-0658A72B-171B-424C-8A06-CC1D2FEE5DD9 Q41682157-E99FC663-364F-4C13-A23B-49AFFBC914D4 Q46220670-3A26B1CC-D24C-4A4C-B7AA-051C64390BF4 Q46255801-7787D0D2-B7F2-4E37-959C-371D4D93B603 Q49154688-429B686C-1B34-4DF4-9EBF-6B39CF345D77 Q50101181-B393B9B1-9AD8-487F-8A29-89203363B554 Q52669796-5C9366F9-FC06-4512-9BEB-D4C6746547F6

P2860

Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables

http://www.wikidata.org/entity/Q26865426

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Asymmetric dimethylarginine an ...... ular and kidney disease tables

@ast

Asymmetric dimethylarginine an ...... ular and kidney disease tables

@en

Asymmetric dimethylarginine an ...... ular and kidney disease tables

@nl

type

label

Asymmetric dimethylarginine an ...... ular and kidney disease tables

@ast

Asymmetric dimethylarginine an ...... ular and kidney disease tables

@en

Asymmetric dimethylarginine an ...... ular and kidney disease tables

@nl

prefLabel

Asymmetric dimethylarginine an ...... ular and kidney disease tables

@ast

Asymmetric dimethylarginine an ...... ular and kidney disease tables

@en

Asymmetric dimethylarginine an ...... ular and kidney disease tables

@nl

P1433

Q26865426-6F8829F1-B9D4-4246-B179-164406AD9F6E

P1476

Q26865426-AF9A6C45-1A8A-4AA2-A0C7-6552D2C77715

P2093

Q26865426-55A91881-F2E0-40DB-AB89-5228E444C416

P2860

Q26865426-01E2F1CA-21B8-4510-A4A5-F53ED35DA29C

Q26865426-02382D9E-3889-4227-8E13-D5A3383574D8

Q26865426-056BE5CA-7BA3-42CF-95ED-C40B94F9B247

Q26865426-0C39CF73-F5B2-4B96-8DCD-446D54A65127

Q26865426-0F6A3068-41CC-44FF-9570-5F3B71BB1731

Q26865426-10591F89-8042-4851-8E2E-11BC1C4CD032

Q26865426-1308F22A-00E2-461B-852D-FF1CD91DB843

Q26865426-13EA5757-050C-4941-955C-9E091D42EEED

Q26865426-1860E5C1-1141-4D2D-B917-307B1B5405D3

Q26865426-1868D39D-DEF6-43A1-998B-04A8F4E43732

P304

Q26865426-5A211731-B493-47E6-A609-3208193E9B2D

P31

Q26865426-E22B947C-8981-40B6-9A98-031EF9E02AF7

P3181

Q26865426-39BC0418-C734-4A85-A03E-E2EE44547C78

P356

Q26865426-1B2096D5-0742-4331-81CD-BE267A4AE843

P407

Q26865426-08ABCDFC-013E-4955-BAED-75C231B660CC

P433

Q26865426-DBD00DEC-A85D-42C7-81DC-B98F70C6DD0C

P478

Q26865426-3F8713FD-8AE5-4297-873B-045D61E259EA

P577

Q26865426-CC225694-4F9F-42E3-8437-D65C81806248

P698

Q26865426-270FBDEC-EEFF-43C6-BE20-0AE6DBF295FF

P921

Q26865426-FD260A49-56C9-4F90-924C-4954FB9293FD

P932

Q26865426-8A0D442C-4D84-4F17-B404-759AB50571D8

P3181

P356

HYPERTENSIONAHA.111.187310

P1433

P1476

Asymmetric dimethylarginine an ...... ular and kidney disease tables

@en

P2093

C. S. Wilcox

http://www.w3.org/2001/XMLSchema#string

P2860

Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production

Effects of tempol and redox-cycling nitroxides in models of oxidative stress.

Chemistry and antihypertensive effects of tempol and other nitroxides

The relationship between dose of vitamin E and suppression of oxidative stress in humans

LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases

Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis

Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling

Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine

RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

P304

375-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2253851

http://www.w3.org/2001/XMLSchema#string

P356

10.1161/HYPERTENSIONAHA.111.187310

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22215715

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

3266466

http://www.w3.org/2001/XMLSchema#string